Metraipolis › archive › dc_e1e98e75313d

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study — Europe PMC PMID:42290320

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42290320
DOI
10.1111/hae.70339
License (as archived)
solo-consultazione
Archived
2026-10-31T11:00:10.461Z
SHA-256 of the archived text
1f31d901461027e6da1de5fcfb9b209ec537d55fc744fa4206bf6205f4187ef8
Stable URL of this page
https://metraipolis.com/documento/dc_e1e98e75313d

How to cite

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study — Europe PMC PMID:42290320 — Europe PMC (en), https://europepmc.org/article/MED/42290320 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e1e98e75313d (Metraipolis archive dc_e1e98e75313d, sha256 1f31d901461027e6da1de5fcfb9b209ec537d55fc744fa4206bf6205f4187ef8)
BibTeX
@misc{dce1e98e75313d,
  title = {Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study — Europe PMC PMID:42290320},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42290320},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e1e98e75313d; sha256 1f31d901461027e6da1de5fcfb9b209ec537d55fc744fa4206bf6205f4187ef8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42290320. Agents can read the archived copy with the MCP tool read_document.